Experimental group:Xianglianwan orally

2 trials

Sponsors

Shanghai TCM-integrated Hospital, Shanghai University of TCM

Conditions

malignant tumors

Early Phase 1

A randomized, controlled, double-blind trial for the efficacy of Xianglianwan in the immunotherapy of advanced malignant tumors

RecruitingITMCTR1900002635

Shanghai TCM-integrated Hospital, Shanghai University of TCMmalignant tumors

Start: 2019-09-29Updated: 2023-02-20

A randomized, controlled, double-blind trial for the efficacy of Xianglianwan in the immunotherapy of advanced malignant tumors

RecruitingChiCTR1900026300

Shanghai TCM-integrated Hospital, Shanghai University of TCMmalignant tumors

Start: 2019-09-29Updated: 2019-09-30

Related Papers

The whole treatment process and thinking of a patient with NUT carcinoma of the parotid gland: a case report

Frontiers in Oncology2023-05-029 citations